DEPAKOTE CP Drug Patent Profile
✉ Email this page to a colleague
When do Depakote Cp patents expire, and when can generic versions of Depakote Cp launch?
Depakote Cp is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in DEPAKOTE CP is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Depakote Cp
A generic version of DEPAKOTE CP was approved as divalproex sodium by APOTEX on July 29th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEPAKOTE CP?
- What are the global sales for DEPAKOTE CP?
- What is Average Wholesale Price for DEPAKOTE CP?
Summary for DEPAKOTE CP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 97 |
| DailyMed Link: | DEPAKOTE CP at DailyMed |
Recent Clinical Trials for DEPAKOTE CP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Puma Biotechnology, Inc. | Phase 1/Phase 2 |
| Virginia Commonwealth University | Phase 1/Phase 2 |
| Barretos Cancer Hospital | Early Phase 1 |
US Patents and Regulatory Information for DEPAKOTE CP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DEPAKOTE CP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | ⤷ Sign Up | ⤷ Sign Up |
| Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | ⤷ Sign Up | ⤷ Sign Up |
| Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | ⤷ Sign Up | ⤷ Sign Up |
| Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-001 | Jul 11, 1990 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DEPAKOTE CP
See the table below for patents covering DEPAKOTE CP around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
